Join the Network

Overview

ALZ-NET is seeking applications for health systems and health care providers to participate in the Network. Please review instructions for becoming a participating site and relevant site and investigator qualifications prior to starting your site registration. 

Become a Participating Site

Begin site registration

1. Review the ALZ-NET Protocol Synopsis. 
2. Submit the 10-minute Site Registration and Feasibility Survey. 
3. The ALZ-NET Operations Team will review your application.
4. If your site is invited to participate, you will receive an email with essential start-up documents and additional instructions. 
5. Once all start-up activities are complete, your site will receive an activation notice and be activated for participation. 

For any questions regarding joining the Network, email alz-net@acr.org.

Site Qualifications

Data collected will describe the multi-disciplinary dementia care team, patient population and enrollment feasibility such as: 

• Access to:
  • Accredited and appropriate radiological services for diagnostic and safety brain imaging
  • Infusion services
  • Emergency services
  • Standard cognitive, behavioral, and functional assessments used in dementia care
• Race and ethnicity percentages of patient population
• Estimated enrollment capabilities based on the ALZ-NET eligibility criteria

Site Investigator Qualifications

• Must hold credentials that authorize prescription of novel FDA-approved therapies.
  • Novel FDA-approved therapies for AD are drugs that have received approval as treatments for Alzheimer's disease (AD) from the U.S. Food and Drug Administration since 2021. 
  • Site Investigator may be a physician, physician assistant, or nurse practitioner.
• All site investigators must have the appropriate education and ability for contact time for evaluation and care of adults with acquired cognitive impairment or dementia.